Cidara Therapeutics Inc CDTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 AM EDT
2.18quote price arrow up+0.04 (+1.87%)
Volume
1,000
Close
2.14quote price arrow up+0.05 (+2.39%)
Volume
299,353
52 week range
1.46 - 3.28
Loading...
  • Open2.08
  • Day High2.18
  • Day Low2.08
  • Prev Close2.14
  • 52 Week High3.28
  • 52 Week High Date10/09/20
  • 52 Week Low1.46
  • 52 Week Low Date07/14/21

Key Stats

  • Market Cap105.95M
  • Shares Out49.51M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta1.37
  • YTD % Change7

KEY STATS

  • Open2.08
  • Day High2.18
  • Day Low2.08
  • Prev Close2.14
  • 52 Week High3.28
  • 52 Week High Date10/09/20
  • 52 Week Low1.46
  • 52 Week Low Date07/14/21
  • Market Cap105.95M
  • Shares Out49.51M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta1.37
  • YTD % Change7

RATIOS/PROFITABILITY

  • EPS (TTM)-1.09
  • P/E (TTM)-1.96
  • Fwd P/E (NTM)-1.47
  • EBITDA (MRQ)-46.276M
  • ROE (MRQ)-163.97%
  • Revenue (MRQ)41.42M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-113.11%
  • Debt To Equity (MRQ)30.45%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cidara Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Cidara Therapeutics, Inc. is a biotechnology company. The Company is focused on the discovery, development and commercialization of therapeutics designed for the care of patients facing serious fungal or viral infections. The Company's lead product candidate is rezafungin acetate, an intravenous formulation of an echinocandin. Rezafungin is being developed as a once-weekly, high-exposure therapy for the treatment and prevention of serious invasive fungal infections....
Daniel Burgess
Non-Executive Chairman
Jeffrey Stein Ph.D.
President
Paul Daruwala
Chief Operating Officer
Preetam Shah Ph.D.
Chief Financial Officer
Brady Johnson
Chief Accounting Officer
Jessica Oien J.D.
General Counsel
Address
6310 Nancy Ridge Dr Ste 101
San Diego, CA
92121-3209
United States

Top Peers

SYMBOLLASTCHG%CHG
ENVB
Enveric Biosciences Inc
2.31-0.23-9.06%
CNCE
Concert Pharmaceuticals Inc
3.62-0.04-1.09%
SBBP
Strongbridge Biopharma plc
2.09+0.10+5.03%
PLX
Protalix Biotherapeutics Inc
1.31UNCHUNCH
XERS
Xeris Pharmaceuticals Inc
2.43+0.06+2.53%